Clinical Trial Update: VRC 605: Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB075-00-AB (VRC07-523LS), Administered Intravenously or Subcutaneously to Healthy Adults [Phase 1]

View source ↗

Summary

Phase 1 safety and pharmacokinetics study of the human monoclonal antibody VRC07-523LS (VRC-HIVMAB075-00-AB) for HIV prevention, with results posted after compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• HIV Prevention

Drugs mentioned

• VRC07-523LS (VRC-HIVMAB075-00-AB) (VRC07-523LS)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Prevention | Phase 1 | Status: COMPLETED | Results posted: 2019-07-11